{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:13:25Z","timestamp":1784002405871,"version":"3.55.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Ebba Rosa Hansen Foundation"},{"name":"Faculty of Health and Medical Sciences, University of Copenhagen, Denmark"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>Does hormone stimulation during assisted reproductive technology (ART) treatment increase the risk of ovarian cancer?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>No increased risk of ovarian cancer was found among ART-treated women, with the exception of ART-treated women with endometriosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>Previous studies on the association between ovarian stimulation during ART and ovarian cancer have shown conflicting results. The risk of ovarian cancer varies according to the cause of infertility, and only a few studies on ART treatment and risk of ovarian cancer have had sufficient data to address this issue. Endometriosis has been linked to an increased risk of ovarian cancer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>Women undergoing ART treatment during 1994\u20132015 were registered in the Danish IVF register. Data were linked with data from the Danish Cancer Register and socio-demographic population registers using an individual person identification number assigned to people residing in Denmark.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>All women undergoing ART treatment were age-matched with a random sample of the female background population and followed for up to 22\u00a0years. After relevant exclusions, the population consisted of 58\u2009472 ART-treated women and 625\u2009330 untreated women, all with no previous malignancies. Ovarian cancer risk was assessed using multivariable cox regression analyses with adjustment for educational level, marital status, parity and treatment year. Results are shown as hazard ratios (HRs) with corresponding CIs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>In total, 393 (0.06%) women were diagnosed with ovarian cancer during follow-up (mean 9.7\u00a0years). Women treated with ART had an increased risk of ovarian cancer (HR 1.20, 95% CI 1.10\u20131.31), which diminished over time. The increased risk was apparent among women with female factor infertility (HR 1.36, 95% CI 1.25\u20131.48), whereas no female factor infertility was associated with a lower risk (HR 0.87, 95% CI 0.76\u20131.00). The risk was increased among women with endometriosis (HR 3.78, 95% CI 2.45\u20135.84), whereas no increased risk was found among ART-treated women with polycystic ovary syndrome, other female causes of infertility and unexplained infertility.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>The association between ART treatment and ovarian cancer is likely influenced by increased detection due to multiple ultrasound scans during ART treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>Undergoing ART treatment without the presence of endometriosis was not associated with an increased risk of ovarian cancer, which is reassuring. Whether ART treatment increases the risk of ovarian cancer among women with endometriosis needs further investigation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                  <jats:p>This work was supported by a PhD grant to D.V. from the Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. Funding for establishing the Danish National ART-couple II cohort was achieved from Ebba Rosa Hansen Foundation. The funders had no influence on data collection, analyses or results presented. The authors have no conflicts of interest to declare.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humrep\/dez165","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T15:10:18Z","timestamp":1564153818000},"page":"2290-2296","source":"Crossref","is-referenced-by-count":31,"title":["Assisted reproductive technology treatment and risk of ovarian cancer\u2014a nationwide population-based cohort study"],"prefix":"10.1093","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6298-4146","authenticated-orcid":false,"given":"D","family":"Vassard","sequence":"first","affiliation":[{"name":"Department of Public Health, Section of Social Medicine, University of Copenhagen, Copenhagen K, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Department of Public Health, Section of Social Medicine, University of Copenhagen, Copenhagen K, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C H","family":"Glazer","sequence":"additional","affiliation":[{"name":"Department of Occupational and Environmental Medicine, Bispebjerg University Hospital, Copenhagen NV, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Lyng Forman","sequence":"additional","affiliation":[{"name":"Department of Public Health, Section of Biostatistics, University of Copenhagen, Copenhagen K, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Kamper-J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"Department of Public Health, Section of Epidemiology, University of Copenhagen, Copenhagen K, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Pinborg","sequence":"additional","affiliation":[{"name":"Fertility Clinic, Rigshospitalet, Copenhagen University Hospital, DK-2100 Copenhagen \u00d8, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,10,10]]},"reference":[{"key":"2019122310593999100_ref1","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMoa1614814","article-title":"Cancer-associated mutations in endometriosis without cancer","volume":"376","author":"Anglesio","year":"2017","journal-title":"N Engl J Med"},{"key":"2019122310593999100_ref2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/GRF.0000000000000320","article-title":"Endometriosis-associated ovarian cancers","volume":"60","author":"Anglesio","year":"2017","journal-title":"Clin Obstet Gynecol"},{"key":"2019122310593999100_ref3","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.fertnstert.2013.02.010","article-title":"Fertility drug use and the risk of ovarian tumors in infertile women: a case\u2013control study","volume":"99","author":"Asante","year":"2013","journal-title":"Fertil Steril"},{"key":"2019122310593999100_ref4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.fertnstert.2004.09.016","article-title":"Ovulation induction and cancer risk","volume":"83","author":"Brinton","year":"2005","journal-title":"Fertil Steril"},{"key":"2019122310593999100_ref5","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/01.AOG.0000128139.92313.74","article-title":"Ovarian cancer risk after the use of ovulation-stimulating drugs","volume":"103","author":"Brinton","year":"2004","journal-title":"Obstet Gynecol"},{"key":"2019122310593999100_ref6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.fertnstert.2004.02.109","article-title":"Ovarian cancer risk associated with varying causes of infertility","volume":"82","author":"Brinton","year":"2004","journal-title":"Fertil Steril"},{"key":"2019122310593999100_ref7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(79)91435-1","article-title":"\u201cIncessant ovulation\u201d and ovarian cancer","volume":"2","author":"Casagrande","year":"1979","journal-title":"Lancet"},{"key":"2019122310593999100_ref8","first-page":"519","article-title":"Ovarian cancer: diagnostic, biological and prognostic aspects","volume":"10","author":"Davidson","year":"2014","journal-title":"Womens Health"},{"key":"2019122310593999100_ref9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/GCO.0000000000000060","article-title":"Use of fertility drugs and risk of ovarian cancer","volume":"26","author":"Diergaarde","year":"2014","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2019122310593999100_ref10","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1093\/humrep\/17.8.2209","article-title":"Cancer incidence following treatment for infertility at a clinic in the UK","volume":"17","author":"Doyle","year":"2002","journal-title":"Hum Reprod"},{"key":"2019122310593999100_ref11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/humrep\/det457","article-title":"ESHRE Guideline: management of women with endometriosis","volume":"29","author":"Dunselman","year":"2014","journal-title":"Hum Reprod"},{"key":"2019122310593999100_ref12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation\u2014a factor in ovarian neoplasia?","volume":"2","author":"Fathalla","year":"1971","journal-title":"Lancet"},{"key":"2019122310593999100_ref13","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/humrep\/dey242","article-title":"ART in Europe, 2014: results generated from European registries by ESHRE: The European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE)","volume":"33","author":"De Geyter","year":"2018","journal-title":"Hum Reprod"},{"key":"2019122310593999100_ref14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/09513590903247873","article-title":"An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome","volume":"26","author":"Glintborg","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"2019122310593999100_ref15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/AOG.0000000000000592","article-title":"Influence of endometriosis on assisted reproductive technology outcomes: a systematic review and meta-analysis","volume":"125","author":"Hamdan","year":"2015","journal-title":"Obstet Gynecol"},{"key":"2019122310593999100_ref16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40738-016-0029-2","article-title":"Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review","volume":"2","author":"Harris","year":"2016","journal-title":"Fertil Res Pract"},{"key":"2019122310593999100_ref17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/AOG.0b013e318291c235","article-title":"Oral contraceptive pills as primary prevention for ovarian cancer","volume":"122","author":"Havrilesky","year":"2013","journal-title":"Obstet Gynecol"},{"key":"2019122310593999100_ref18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/aogs.12255","article-title":"The relation between endometriosis and ovarian cancer\u2014a review","volume":"93","author":"Heidemann","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2019122310593999100_ref19","first-page":"CD000057","article-title":"Clomiphene citrate for unexplained subfertility in women","volume":"1","author":"Hughes","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2019122310593999100_ref20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GRF.0b013e31824b4611","article-title":"Ovarian cancer: etiology, risk factors, and epidemiology","volume":"55","author":"Hunn","year":"2012","journal-title":"Clin Obstet Gynecol"},{"key":"2019122310593999100_ref21","doi-asserted-by":"crossref","first-page":"b249","DOI":"10.1136\/bmj.b249","article-title":"Use of fertility drugs and risk of ovarian cancer: Danish population based cohort study","volume":"338","author":"Jensen","year":"2009","journal-title":"BMJ"},{"key":"2019122310593999100_ref22","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1158\/1055-9965.EPI-12-0426","article-title":"Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case\u2013control study","volume":"21","author":"Kurta","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2019122310593999100_ref23","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer\u2014viewpoint of the IARC Working Group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N Engl J Med"},{"key":"2019122310593999100_ref24","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1093\/humrep\/der322","article-title":"Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort","volume":"26","author":"Van Leeuwen","year":"2011","journal-title":"Hum Reprod"},{"key":"2019122310593999100_ref25","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/humrep\/det023","article-title":"Pre-gravid oral contraceptive use and time to pregnancy: a Danish prospective cohort study","volume":"28","author":"Mikkelsen","year":"2013","journal-title":"Hum Reprod"},{"key":"2019122310593999100_ref26","first-page":"178","article-title":"Gonadotrophins and ovarian cancer risk","volume":"75","author":"Mohle","year":"1985","journal-title":"J Natl Cancer Inst"},{"key":"2019122310593999100_ref27","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/humrep\/dez018","article-title":"Risk of cancer in infertile women: analysis of US claims data","volume":"34","author":"Murugappan","year":"2019","journal-title":"Hum Reprod"},{"key":"2019122310593999100_ref28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s13669-017-0187-1","article-title":"Endometriosis: epidemiology, diagnosis and clinical management","volume":"6","author":"Parasar","year":"2017","journal-title":"Curr Obstet Gynecol Rep"},{"key":"2019122310593999100_ref29","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/aje\/kwh315","article-title":"A case\u2013control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs","volume":"160","author":"Rossing","year":"2004","journal-title":"Am J Epidemiol"},{"key":"2019122310593999100_ref30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-5573-5-7","article-title":"Methods for stratification of person-time and events\u2014a prerequisite for Poisson regression and SIR estimation","volume":"5","author":"Rostgaard","year":"2008","journal-title":"Epidemiol Perspect Innov"},{"key":"2019122310593999100_ref31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ygyno.2012.10.023","article-title":"In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk","volume":"128","author":"Stewart","year":"2013","journal-title":"Gynecol Oncol"},{"key":"2019122310593999100_ref32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000052872","article-title":"Evidence that endometriosis behaves in a malignant manner","volume":"50","author":"Thomas","year":"2000","journal-title":"Gynecol Obstet Invest"},{"key":"2019122310593999100_ref33","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/bjc.2011.371","article-title":"Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European prospective investigation into cancer and nutrition","volume":"105","author":"Tsilidis","year":"2011","journal-title":"Br J Cancer"},{"key":"2019122310593999100_ref34","article-title":"Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991\u20132010: data linkage study including 2.2 million person years of observation","volume":"362","author":"Williams","year":"2018","journal-title":"BMJ"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/34\/11\/2290\/31206610\/dez165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/34\/11\/2290\/31206610\/dez165.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T11:37:55Z","timestamp":1577101075000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/34\/11\/2290\/5584449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,10]]},"references-count":34,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,10,10]]},"published-print":{"date-parts":[[2019,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dez165","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11]]},"published":{"date-parts":[[2019,10,10]]}}}